Peter Sedgwick
Director/Miembro de la Junta en 3i Infrastructure (Luxembourg) Holdings SARL .
Perfil
Peter Sedgwick is currently a Director at 3i Infrastructure (Luxembourg) Holdings SARL and 3i Infrastructure (Luxembourg) SARL.
Previously, he served as the Non-Executive Chairman at 3i Infrastructure Plc from 2009 to 2016.
He also served as the Chairman at Bowel Cancer UK.
Cargos activos de Peter Sedgwick
| Empresas | Cargo | Inicio |
|---|---|---|
| 3i Infrastructure (Luxembourg) Holdings SARL | Director/Miembro de la Junta | - |
| 3i Infrastructure (Luxembourg) SARL | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Peter Sedgwick.
| Empresas | Cargo | Fin |
|---|---|---|
| 3I INFRASTRUCTURE PLC | Presidente | 01/01/2016 |
Bowel Cancer UK
 Bowel Cancer UK Investment Trusts/Mutual FundsMiscellaneous Bowel Cancer UK operates as a charity focused on bowel cancer. The non-profit company is based in London, UK. The British company was founded in 1987. Genevieve Edwards has been the CEO of the company since 2020. | Presidente | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
3i Infrastructure Plc
 3i Infrastructure Plc Investment ManagersFinance 3i Infrastructure Plc acts as a private equity fund, which invests in infrastructure businesses and assets in the UK, Europe and North America. The fund focuses on range of investment opportunities across adjacent sectors to utilities, transportation, communications and energy. It provides financing for infrastructure capital requirements. The company was founded on January 16, 2007 and is headquartered in St. Helier, the United Kingdom. | Finance |
| 3i Infrastructure (Luxembourg) Holdings SARL | |
| 3i Infrastructure (Luxembourg) SARL | |
Bowel Cancer UK
Bowel Cancer UK Investment Trusts/Mutual FundsMiscellaneous Bowel Cancer UK operates as a charity focused on bowel cancer. The non-profit company is based in London, UK. The British company was founded in 1987. Genevieve Edwards has been the CEO of the company since 2020. | Miscellaneous |
- Bolsa de valores
- Insiders
- Peter Sedgwick
